BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36131041)

  • 1. Compartment-specific mutational landscape of clonal hematopoiesis.
    Hartmann L; Hecker JS; Rothenberg-Thurley M; Rivière J; Jentzsch M; Ksienzyk B; Buck MC; van der Garde M; Fischer L; Winter S; Rauner M; Tsourdi E; Weidner H; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Lützner J; Goralski S; Bassermann F; Spiekermann K; Hofbauer LC; Schwind S; Platzbecker U; Götze KS; Metzeler KH
    Leukemia; 2022 Nov; 36(11):2647-2655. PubMed ID: 36131041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with clonal hematopoiesis and interaction with marrow environment.
    Nannya Y
    J Bone Miner Metab; 2023 May; 41(3):380-387. PubMed ID: 36346484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Mapping of Hematopoietic Clones in Human Bone Marrow.
    Young AL; Davis HC; Cox MJ; Parsons TM; Burkart SC; Bender DE; Sun L; Oh ST; Challen GA
    Blood Cancer Discov; 2024 May; 5(3):153-163. PubMed ID: 38421682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
    van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
    Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
    Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
    Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of clonal hematopoiesis in Erdheim-Chester disease.
    Cohen Aubart F; Roos-Weil D; Armand M; Marceau-Renaut A; Emile JF; Duployez N; Charlotte F; Poulain S; Lhote R; Hélias-Rodzewicz Z; Della-Valle V; Bernard O; Maloum K; Nguyen-Khac F; Donadieu J; Amoura Z; Abdel-Wahab O; Haroche J
    Blood; 2021 Jan; 137(4):485-492. PubMed ID: 33067622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
    Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
    Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.
    Osman AEG; Mencia-Trinchant N; Saygin C; Moma L; Kim A; Housman G; Pozsgai M; Sinha E; Chandra P; Hassane DC; Sboner A; Sangani K; DiNardi N; Johnson C; Wallace SS; Jabri B; Luu H; Guzman ML; Desai P; Godley LA
    Blood Adv; 2023 May; 7(9):1910-1914. PubMed ID: 36453641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population.
    van Zeventer IA; de Graaf AO; Salzbrunn JB; Nolte IM; Kamphuis P; Dinmohamed A; van der Reijden BA; Schuringa JJ; Jansen JH; Huls G
    Cancer Cell; 2023 Jun; 41(6):1017-1031.e4. PubMed ID: 37146604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals.
    van Zeventer IA; de Graaf AO; Koorenhof-Scheele TN; van der Reijden BA; van der Klauw MM; Dinmohamed AG; Diepstra A; Schuringa JJ; Malcovati L; Huls G; Jansen JH
    Blood Adv; 2022 Jul; 6(14):4174-4184. PubMed ID: 35561316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of clonal hematopoiesis in VEXAS syndrome.
    Gutierrez-Rodrigues F; Kusne Y; Fernandez J; Lasho T; Shalhoub R; Ma X; Alessi H; Finke C; Koster MJ; Mangaonkar A; Warrington KJ; Begna K; Xie Z; Ombrello AK; Viswanatha D; Ferrada M; Wilson L; Go R; Kourelis T; Reichard K; Olteanu H; Darden I; Hironaka D; Alemu L; Kajigaya S; Rosenzweig S; Calado RT; Groarke EM; Kastner DL; Calvo KR; Wu CO; Grayson PC; Young NS; Beck DB; Patel BA; Patnaik MM
    Blood; 2023 Jul; 142(3):244-259. PubMed ID: 37084382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers.
    Gurnari C; Visconte V
    Leuk Res; 2023 Apr; 127():107038. PubMed ID: 36841022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119.
    Köhnke T; Nuno KA; Alder CC; Gars EJ; Phan P; Fan AC; Majeti R
    Blood Cancer Discov; 2024 May; 5(3):202-223. PubMed ID: 38359087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis.
    Stacey SN; Zink F; Halldorsson GH; Stefansdottir L; Gudjonsson SA; Einarsson G; Hjörleifsson G; Eiriksdottir T; Helgadottir A; Björnsdottir G; Thorgeirsson TE; Olafsdottir TA; Jonsdottir I; Gretarsdottir S; Tragante V; Magnusson MK; Jonsson H; Gudmundsson J; Olafsson S; Holm H; Gudbjartsson DF; Sulem P; Helgason A; Thorsteinsdottir U; Tryggvadottir L; Rafnar T; Melsted P; Ulfarsson MÖ; Vidarsson B; Thorleifsson G; Stefansson K
    Nat Genet; 2023 Dec; 55(12):2149-2159. PubMed ID: 37932435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.